Q32 Bio Inc. (QTTB)
Pharmaceutical Preparations · Healthcare · $187M
Intrinsic Value (Consensus)
$28.13
Current Price
$12.75
Margin of Safety
+120.6%
120.6% Below Intrinsic Value
Value: $28
Price: $13
Valuation Model Estimates
Current Price: $12.75
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
$12.50
Earnings Power Value
$23.50
Relative Value (P/E)
$48.40
Dividend Discount Model
Not applicable
—
Consensus Value
$28.13
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
58
Profitability
25/25
Strength
7/25
Valuation
22/25
Growth
4/25
Financial Health Signals
Negative free cash flow — company is burning cash
Declining revenue — top line is shrinking
Strong profitability — ROE of 71% (above 20% is excellent)
Key Financials
- EPS (TTM)
- $2.42
- EPS (Forward)
- $2.54
- Book Value
- $2.87
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 71.0%
- Debt/Equity
- —
- Revenue Growth
- -64.0%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance